FI771866A - - Google Patents

Info

Publication number
FI771866A
FI771866A FI771866A FI771866A FI771866A FI 771866 A FI771866 A FI 771866A FI 771866 A FI771866 A FI 771866A FI 771866 A FI771866 A FI 771866A FI 771866 A FI771866 A FI 771866A
Authority
FI
Finland
Application number
FI771866A
Other languages
Finnish (fi)
Inventor
Takashi Kamiya
Takao Takaya
Tsutomu Teraji
Masashi Hashimoto
Osamu Nakaguti
Teruo Oku
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB26740/76A external-priority patent/GB1580189A/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI771866A publication Critical patent/FI771866A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
FI771866A 1976-06-28 1977-06-14 FI771866A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB26740/76A GB1580189A (en) 1976-06-28 1976-06-28 Cephalosporin derivatives and the preparation thereof
GB26277 1977-01-05

Publications (1)

Publication Number Publication Date
FI771866A true FI771866A (sv) 1977-12-29

Family

ID=26235798

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771866A FI771866A (sv) 1976-06-28 1977-06-14

Country Status (23)

Country Link
US (1) US4225707A (sv)
JP (1) JPS5932475B2 (sv)
AR (2) AR218254A1 (sv)
AT (1) AT353963B (sv)
AU (1) AU512804B2 (sv)
CA (2) CA1102307A (sv)
CH (3) CH634074A5 (sv)
CS (1) CS196371B2 (sv)
DE (1) DE2728766A1 (sv)
DK (1) DK284977A (sv)
ES (5) ES460083A1 (sv)
FI (1) FI771866A (sv)
FR (1) FR2356654A1 (sv)
GR (1) GR68939B (sv)
HU (1) HU179181B (sv)
IE (1) IE45222B1 (sv)
NL (1) NL7707150A (sv)
NO (1) NO772257L (sv)
NZ (1) NZ184493A (sv)
OA (1) OA05688A (sv)
PT (1) PT66728B (sv)
SE (1) SE438337B (sv)
SU (1) SU856387A3 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5498795A (en) * 1978-01-13 1979-08-03 Takeda Chem Ind Ltd Cephalosporin derivative and its preparation
MA18686A1 (fr) * 1978-07-07 1980-10-01 Ciba Geigy Ag Composes aminothiazoliques
US4305937A (en) * 1978-08-17 1981-12-15 Fujisawa Pharmaceutical Co., Ltd. 2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds and antibacterial pharmaceutical compositions containing them
EP0009671B1 (en) * 1978-09-12 1984-06-13 Fujisawa Pharmaceutical Co., Ltd. Starting compounds for preparing cephem compounds and processes for their preparation
EP0021688B1 (en) * 1979-06-07 1983-07-13 Yamanouchi Pharmaceutical Co., Ltd. 7-(thiazolylpropionamido) cephalosporins, their preparation, and pharmaceutical compositions containing them
US4443374A (en) * 1982-02-01 1984-04-17 E. R. Squibb & Sons, Inc. Process for preparing (3S)-3-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]-acetyl]amino]-2-oxo-1-azetidinesulfonic acid, and 4-substituted derivatives
JPS5946287A (ja) * 1982-07-23 1984-03-15 Meiji Seika Kaisha Ltd 新規１−オキサ−１−デチア−セフアロスポリン誘導体
JPS63107977A (ja) * 1986-05-21 1988-05-12 Takeda Chem Ind Ltd イソオキサゾロン誘導体
JPH09110877A (ja) * 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH557381A (de) * 1967-04-15 1974-12-31 Fujisawa Pharmaceutical Co Verfahren zur herstellung von (delta)3-cephemverbindungen.
GB1241656A (en) * 1967-08-21 1971-08-04 Glaxo Lab Ltd Improvements in or relating to cephalosporin compounds
GB1279402A (en) * 1968-06-14 1972-06-28 Glaxo Lab Ltd Improvements in or relating to cephalosporin derivatives
US3719672A (en) * 1968-12-11 1973-03-06 Ciba Geigy Corp 4-substituted methylene-7-amino-8-oxo-5-thia-1-aza-bicyclo(4,2,0 oct-2-ene-2-carboxylic acids
GB1453049A (en) * 1973-08-21 1976-10-20 Glaxo Lab Ltd Cephalosporing antibiotics
GB1445979A (en) * 1972-10-25 1976-08-11 Glaxo Lab Ltd Cephalosporin derivatives
AR208283A1 (es) * 1973-03-15 1976-12-20 Fujisawa Pharmaceutical Co Un procedimiento para la preparacion de derivados de acido 2-alquil-2-o 3-fefem-4-carboxilico
JPS5932472B2 (ja) * 1973-03-15 1984-08-09 藤沢薬品工業株式会社 ２−アルキル−７−アシルアミノ−２（または３）−セフエム−４−カルボン酸類の製造法
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
JPS5652908B2 (sv) * 1974-07-17 1981-12-15
JPS50111093A (sv) * 1974-02-20 1975-09-01
JPS5512913B2 (sv) * 1974-11-13 1980-04-04
JPS5932473B2 (ja) * 1974-02-20 1984-08-09 藤沢薬品工業株式会社 ７−アシルアミノ−２（または３）−セフエム−４−カルボン酸類の製造法
US3928333A (en) * 1974-05-20 1975-12-23 Lilly Co Eli Process for the preparation of 3 cephalosporin esters
GB1480027A (en) * 1974-05-24 1977-07-20 Bristol Myers Co Cephalosporin derivatives
FR2286138A1 (fr) * 1974-09-27 1976-04-23 Rhone Poulenc Ind Nouveaux acides oxathiino- et dithiino-aminoacetiques et leur preparation
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
JPS5246093A (en) * 1975-10-03 1977-04-12 Fujisawa Pharmaceut Co Ltd 2-alkyl-7-substituted-2, or 3-cephem-4-carboxylic compounds, their sal ts, and preparation thereof

Also Published As

Publication number Publication date
AT353963B (de) 1979-12-10
PT66728B (en) 1978-11-22
NO772257L (no) 1977-12-29
CH634074A5 (de) 1983-01-14
JPS5932475B2 (ja) 1984-08-09
PT66728A (en) 1977-07-01
CA1117104A (en) 1982-01-26
AU2651977A (en) 1979-01-04
DE2728766A1 (de) 1978-01-05
HU179181B (en) 1982-09-28
ES470756A1 (es) 1979-09-01
SU856387A3 (ru) 1981-08-15
ES460083A1 (es) 1978-10-01
ES470757A1 (es) 1979-02-16
ATA449177A (de) 1979-05-15
ES470754A1 (es) 1979-09-01
IE45222L (en) 1977-12-28
CA1102307A (en) 1981-06-02
JPS535193A (en) 1978-01-18
GR68939B (sv) 1982-03-29
FR2356654A1 (fr) 1978-01-27
AR221601A1 (es) 1981-02-27
SE7707407L (sv) 1977-12-29
US4225707A (en) 1980-09-30
NZ184493A (en) 1980-03-05
CH640539A5 (de) 1984-01-13
OA05688A (fr) 1981-05-31
SE438337B (sv) 1985-04-15
CH640538A5 (de) 1984-01-13
ES470755A1 (es) 1979-09-01
AU512804B2 (en) 1980-10-30
FR2356654B1 (sv) 1981-06-19
NL7707150A (nl) 1977-12-30
IE45222B1 (en) 1982-07-14
CS196371B2 (en) 1980-03-31
DK284977A (da) 1977-12-29
AR218254A1 (es) 1980-05-30

Similar Documents

Publication Publication Date Title
FR2356654B1 (sv)
JPS5627614B2 (sv)
JPS5516057B2 (sv)
JPS5635831B2 (sv)
JPS52103149U (sv)
JPS52163593U (sv)
JPS5721256Y2 (sv)
CS177436B1 (sv)
JPS51156880U (sv)
JPS52153443U (sv)
JPS5310855U (sv)
JPS5324380U (sv)
CS177791B1 (sv)
JPS5294652U (sv)
CH595003A5 (sv)
CH607331A5 (sv)
CH599797A5 (sv)
CH601533A5 (sv)
CH596413A5 (sv)
CH613051A5 (sv)
CH594528A5 (sv)
CH601826A5 (sv)
CH602263A5 (sv)
CH594023A5 (sv)
CH593115A5 (sv)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD